- Lobbying
- biotechnology AND industry AND organization AND bio
Lobbying Arrangements Results for 'Biotechnology Industry Organization Bio'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details 2022 Tax policy initiatives regarding state tax trends. |
Biotechnology Innovation Organization (BIO)
|
Honigman LLP | |||
Details Intellectual property issues. |
Biotechnology Industry Organization (BIO)
|
Hughes, Hubbard & Reed | |||
Details SBIR Reauthorization; venture backed firm eligibility for the SBIR Program. |
Biotechnology Industry Organization (BIO)
|
PATTON BOGGS LLP | |||
Details Patent Reform Issues that are important to the biotechnology industry; HR 1908/ S 1145, Patent Reform Act |
Biotechnology Industry Organization
|
FOLEY & LARDNER LLP | |||
Details Legislation to increase the bioeconomy, biomanufacturing and biomaterials Issues related to appropriations for biomanufacturing Implementation of EO to increase biomanufacturing Farm Bill Legislat... |
Biotechnology Innovation Organization (BIO)
|
Jim Massie & Partners, LLC | |||
Details Promotion of bio-based products and Biotechnology. HR 3221 Foreclosure Prevention Act of 2008- issues pertatining to Accelerated R & D credits. |
BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)
|
TCH Group, LLC | |||
Details Issues related to capital formation and capital markets. |
("Bio") Biotechnology Industry Organization
|
PORTERFIELD, FETTIG & SEARS, LLC | |||
Details Renewable fuels policy Legislation impacting the RFS |
BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO)
|
ALPINE GROUP, INC. | |||
Details Misc. energy incentives for biofuels and incentive for bio-based materials. Algae biofuels; cellulosic biofuels incentives; Extension of second generation biofuels tax incentives IRC Section 40. |
Biotechnology Innovation Organization
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Antibiotic Use in Livestock ---H.R.4012: To repeal the guidance titled "CVM GFI #263 Recommendations for Sponsors of Medically Important Antimicrobial Drugs Approved for Use in Animals to Voluntar... |
Biotechnology Innovation Organization
|
in-house lobbying |